- France
- /
- Healthcare Services
- /
- ENXTPA:EMEIS
emeis (ENXTPA:EMEIS) Losses Increase 2.7% Annually, Challenging Turnaround Optimism
Reviewed by Simply Wall St
emeis Société anonyme (ENXTPA:EMEIS) remains unprofitable, with net losses having increased at an average rate of 2.7% per year over the past five years. Revenue is forecast to grow at 4.3% annually, which is a slower pace than the 5.4% expected for the overall French market. Net profit margins have not improved as the company continues to operate at a loss. While the share price has not maintained stable performance in recent months, the stock currently trades at a significant discount to estimated fair value. This makes valuation a key point for investors weighing persistent losses against potential upside.
See our full analysis for emeis Société anonyme.The next section takes a closer look at how the headline results stand up against widely held market narratives, highlighting where the story is confirmed and where assumptions get tested.
Curious how numbers become stories that shape markets? Explore Community Narratives
Losses Climb at a 2.7% Annual Pace
- Over the past five years, net losses have grown by an average of 2.7% per year, showing that emeis is not making headway on the bottom line despite revenue expansion.
- Bulls often claim that gradual revenue growth will eventually power a turnaround, but the recurring inability to shrink losses puts that optimism under pressure.
- The lack of profit margin improvement means ongoing costs are absorbing all gains from new revenue. This hinders the bullish case for eventual profitability.
- Persistent unprofitability may overshadow management's ambitions for future expansion and challenges narratives that cite sector-wide growth as an easy fix for losses.
Revenue Growth Lags Market Trend
- EMEIS projects revenue growth of 4.3% per year, trailing the overall French market, which is expected to grow 5.4% annually.
- While some see sector momentum as a buffer against slower company-level performance, the muted top-line expansion highlights structural headwinds that cannot be offset by market growth alone.
- Analysts observe that EMEIS’s revenue pace risks falling behind not just peers but also shifting industry benchmarks. This underlines the need for operational pivots.
- The company's forecast underperformance signals that competitive advantages seen elsewhere in the sector may not be translating to EMEIS.
Significant Discount to DCF Fair Value
- Shares trade at €14.61, sitting well below a DCF fair value estimate of €33.30. This suggests considerable upside if the company can address ongoing losses.
- The prevailing market view frames this steep discount as an opportunity for value-focused investors. That view is complicated by EMEIS’s ongoing losses and its lag behind industry growth rates.
- Even with a low price-to-sales ratio versus peers, EMEIS must prove it can narrow losses to justify re-rating toward fair value.
- The disconnect between pricing and performance may persist until there is tangible progress on margins, regardless of sector-wide bullish sentiment.
Next Steps
Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on emeis Société anonyme's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.
See What Else Is Out There
emeis continues to face persistent losses and slower revenue growth, which puts pressure on its turnaround prospects and exposes investors to ongoing risks.
If consistent profitability matters to you, use stable growth stocks screener to identify companies that regularly deliver steady earnings and revenue growth across changing market conditions.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About ENXTPA:EMEIS
emeis Société anonyme
Operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals.
Undervalued with imperfect balance sheet.
Similar Companies
Market Insights
Community Narratives


